We have elucidated the spatial arrangement of proteins and snRNP subunits within the purified spliceosomal B act complex from Saccharomyces cerevisiae, using negative-stain immunoelectron microscopy. The B act spliceosome exhibits a mushroom-like shape with a main body connected to a foot and a steep and a shallow slope. The U5 core components, including proteins Snu114 and Prp8, are located in the main body and foot, while Brr2 is on the shallow slope. U2 snRNP components and the RNA helicase Prp2 were predominantly located in the upper regions of both slopes. While several proteins of the "nineteen complex" are located on the steep slope, Prp19, Cef1, and the U6 snRNA-binding protein Cwc2 are on the main body. Our results also indicate that the catalytic core RNP of the spliceosome resides in its main body. We thus assign distinct domains of the B act complex to its snRNP and protein components, and we provide first structural insights into the remodeling events at the spliceosome during its transformation from the B to the B act complex.
INTRODUCTION
The spliceosome is a highly dynamic molecular machine that assembles de novo for each new round of pre-mRNA splicing by the sequential recruitment to the intron of the U1, U2, and U4/U6·U5 small nuclear ribonucleoproteins (snRNPs) and numerous non-snRNP proteins. The snRNPs comprise an snRNA molecule and numerous proteins, reviewed elsewhere (Will and Lührmann 2011) . All the spliceosomal snRNAs, except the U6 snRNA, are characterized by a 2,2,7-trimethylguanosine (m 3 G) cap structure at their 5 ′ ends (Reddy et al. 1974; Branlant et al. 1982; Busch et al. 1982) and are tightly bound by a heptameric, ring-shaped Sm protein complex near their respective 3 ′ end. The U6 snRNA has a γ-methylguanosine cap at its 5 ′ end (Singh and Reddy 1989) and an LSm ring at its 3 ′ end. The spliceosome undergoes a series of remodeling steps that are driven by eight conserved DExD/H-box ATPases or RNA helicases (Cordin et al. 2012; Cordin and Beggs 2013) . During the course of spliceosome assembly, the snRNPs bind to the pre-mRNA in a stepwise manner. Initially, U1 snRNP forms a base-pairing interaction with the 5 ′ splice site (SS) of the intron; recruitment of the U2 snRNP to the branch-point (BP) sequence (BPS) yields the A complex. U2 snRNA forms a base-pairing interaction with the BPS nucleotides, while several proteins of the U2-associated SF3a and SF3b complexes stabilize the binding of the U2 snRNP to the intron by interacting with intron nucleotides upstream and downstream from the BPS (Gozani et al. 1996; Schneider et al. 2015) . The U4/U6·U5 tri-snRNP, in which the U4 and U6 snRNAs are extensively base paired to one another, associates with the A complex, and a short helix between the 5 ′ end of the U2 and the 3 ′ end of the U6 snRNAs (U2/U6 helix II) is formed. Immediately before, or concomitantly with, the integration of the tri-snRNP, the U1-5 ′ SS interaction is disrupted (Staley and Guthrie 1999) and the U1 snRNP is destabilized ). This event frees the 5 ′ SS and allows it to base pair with the ACAGA box of U6 snRNA (Kandels-Lewis and Séraphin 1993; Lesser and Guthrie 1993) , resulting in formation of the precatalytic B complex in which the catalytic RNA network that forms the spliceosome's catalytic center is not yet established.
Activation of the spliceosome, yielding the B act complex, involves unwinding of the U4/U6 duplex by the RNA helicase Brr2 (Raghunathan and Guthrie 1998) . This allows the U6 snRNA to interact with the U2 snRNA and to form the U2/U6 helices Ia and Ib, and an internal stem-loop (ISL) that is homologous to domain V of self-splicing group II introns (Keating et al. 2010) . Concomitantly with these events, the U5 snRNA loop I base pairs with the 5 ′ exon adjacent to the 5 ′ SS (Wyatt et al. 1992; Sontheimer and Steitz 1993) ; at the same time as these RNA rearrangements, the U1 and U4 snRNAs, all U1 and U4/U6 snRNP proteins, the U4/U6·U5 tri-snRNP proteins, and several of the U5 snRNP proteins (except for Brr2, Prp8, Snu114 and the Sm proteins) are released from the spliceosome (Fig. 1A) . All the U2 snRNP proteins, including Lea1 and the SF3a and SF3b complexes, remain associated with the B act complex (Caspary and Séraphin 1998; Fabrizio et al. 2009 ). Several proteins that are loosely associated with the B complex, including the 10 proteins of the Prp19 core complex (NTC), and all three proteins of the RES (retention and splicing) complex, are stably integrated into the B act complex (Dziembowski et al. 2004; Fabrizio et al. 2009; Hogg et al. 2010) . Several new proteins not found in the B complex are recruited to the B act complex (these proteins are termed B act proteins). Therefore, the yeast S. cerevisiae B act complex comprises the U2/U6/U5/premRNA interaction network (Datta and Weiner 1991; Wu and Manley 1991; Madhani and Guthrie 1994) and approximately 40 proteins (summarized in Supplemental Fig. S1 ), and it represents the spliceosome after activation and before the catalysis of step 1, in which the major RNA rearrangements needed to form an active catalytic center are thought to have occurred (Fica et al. 2014) .
For catalytic activation, the B act complex is remodeled by the RNA helicase Prp2 in cooperation with its G-patch protein cofactor Spp2, yielding the B * complex (Roy et al. 1995; Silverman et al. 2004; Warkocki et al. 2009 Warkocki et al. , 2015 , in which step 1 catalysis occurs, whereby the 2 ′ hydroxyl group of the BP adenosine attacks the 5 ′ SS, generating the cleaved-off 5 ′ exon and the intron-lariat (IL)-3 ′ exon intermediates (Chiu et al. 2009; Warkocki et al. 2009 ). The newly formed C complex catalyzes step 2 of splicing, leading to exon ligation (Horowitz 2012) . The mature mRNA then dissociates from the intron-lariat spliceosome (ILS).
The dynamic nature of the spliceosome and the compositional and conformational heterogeneity of the purified complexes together make structural analysis challenging. Recently, medium-to high-resolution three-dimensional (3D) structures of the U4/U6·U5 tri-snRNP from S. cerevisiae (Nguyen et al. 2015 (Nguyen et al. , 2016a Wan et al. 2016 ) and from human (Agafonov et al. 2016) were determined by electron cryo-microscopy (cryo-EM). Likewise, the cryo-EM structure of S. pombe's endogenous post-catalytic ILS was elucidated at a resolution of 3.6 Å (Yan et al. 2015 ; for review, see Nguyen et al. 2016b) . The latter structure revealed that the spliceosomal RNA network after splicing catalysis is structurally similar to the catalytic core of self-splicing group II introns. It also revealed that the RNA core is embedded in an intricate protein-RNA interaction network, with Prp8 playing a central role in docking the catalytic RNA elements, and other proteins-for example Cef1/CDC5-making further contacts with the RNA core. However, Brr2 and the FIGURE 1. Structure of the yeast spliceosomal B act complex and strategy used to locate C-terminally TAP-tagged Brr2 within B act complex dimers created by anti-TAP antibody. (A) Schematic depiction of splicing events occurring during spliceosome activation. The assembled spliceosomal B complex undergoes dramatic changes, including the release of U1 and U4, stable recruitment of NTC and other splicing factors, and formation of the catalytic RNA network, to generate the B act complex, which then is activated for step 1 catalysis by the ATPase/helicase Prp2 and its cofactor Spp2. (B) Domains of the yeast B act complex. The B act complex exhibits a mushroom-like shape consisting of the steep slope, the shallow slope, and the main body, with a foot domain protruding downward from the bottom of the main body. A gap along the interface between the steep slope and the main body is shown by a short line, and a hole under the shallow slope is shown by a closed loop. The main body is colored gray. (C) Four major class averages and corresponding raw EM images of yeast B act . B act complexes were purified from Saccharomyces cerevisiae bearing a TAP tag at C terminus of Cwc2 and viewed in the electron microscope. Class averages are shown in the upper panel and raw images in the lower panel. The scale bar represents 30 nm. (D) Schematic depiction of anti-TAP antibody-induced B act complex dimerization that is used to locate a TAP-tagged protein in the spliceosomal B act complex. The B act complexes are depicted in the main view, the TAP tag are shown in green, and the antibodies with their characteristic Y shape in brown. (E) Six representative Brr2 C-terminally TAP-tagged B act dimers formed with the anti-TAP antibody. The upper panel shows the raw images. The lower panel shows the corresponding schematic depiction and possible area of TAP tag location within the main-view particle. The outline of the marker particle at the dimerization interface with the main-view particle is drawn as a red line, and the area within 14 nm of the marker particle outline at the particle interface is shown as a transparent red area. (F) The left panel shows the area of maximum overlap deduced from overlaying all dimers of the data set (dark gray). The right panel shows the final location in the B act complex depicted as a transparent dark area. U2 snRNP proteins that make up the SF3a and SF3b complexes are missing from the endogenous ILS structure (Yan et al. 2015) . A medium-resolution structure of a human C complex assembled in vitro revealed only approximately the location of the U5 and U2 snRNP components ; therefore, their spatial arrangement in active spliceosomes immediately before and after step 1 catalysis remains to be elucidated.
So far, the structure of the B act complex has only been studied by 2D EM. 2D class averages of B act complexes from yeast and from human showed a similar mushroom-like appearance Bessonov et al. 2010) . Comparison with the respective B and C complexes revealed that the morphology of human and yeast B act spliceosomes changes significantly during activation and catalysis Bessonov et al. 2010 ). This indicated that major 3D structural rearrangements occur during the transitions from the B to the B act to the C complex and probably also to the post-catalytic ILS.
We previously reported a negative-stain EM-based method to locate spliceosomal proteins in the yeast B complex (Rigo et al. 2015) . This work represented the first extensive mapping of a fully assembled spliceosome and led to a better understanding of its architecture. This method makes use of genetically TAP-tagged proteins that are incorporated into the spliceosome. The spliceosomal particles are dimerized specifically by the addition of anti-TAP antibodies and the dimeric spliceosomes were used to localize proteins in negative-stain EM images (Rigo et al. 2015) . The protein locations revealed extensive similarities with those previously mapped in the yeast tri-snRNP (Häcker et al. 2008) and also with the positions of proteins in the recently determined 3D cryo-EM structure of the tri-snRNP from S. cerevisiae (Nguyen et al. 2015 (Nguyen et al. , 2016a Wan et al. 2016) . This similarity was revealed by fitting the tri-snRNP into the B complex (Rigo et al. 2015) .
Here we used this approach to conduct extensive mapping of protein positions in the yeast B act complex. We located several proteins from the various subcomplexes associated with the B act complex (asterisks in Supplemental Fig. S1 ), including Brr2, the U2 SF3a/b components, and those that were suggested to play a role in the formation of the catalytic RNP core such as Cwc2, Cwc21, and Cwc24 (Grainger et al. 2009; McGrail et al. 2009; Ohrt et al. 2012; Rasche et al. 2012) . We also located the m 3 G cap structure of the U2 and U5 snRNAs. These locations represent a comprehensive mapping of the activated B act spliceosome. Understanding the organization of snRNPs and non-snRNP proteins at the B act stage and comparing it with that in the B complex provides important insights into the remodeling events necessary for activation and step 1 catalysis. Furthermore, on the basis of extensive knowledge about protein-RNA interactions in the B act complex and the recent cryo-EM structures (for review, see Nguyen et al. 2016b ) the positions of catalytic RNA elements can be deduced from the respective protein positions.
RESULTS
Purification, morphology, and immunolabeling of yeast spliceosomal B act complexes
In vitro assembly of spliceosomal complexes in yeast wholecell extract can be stalled at the B act stage either (i) by using a wild-type extract and a pre-mRNA construct that is truncated 6 nucleotides (nt) downstream from the BPS and lacks a 3 ′ SS (M3-ActinΔ6) ); or (ii) by using extracts from yeast strains that express a temperature-sensitive Prp2 mutant (prp2-1) (Kim and Lin 1996; Warkocki et al. 2009 ) together with full-length M3-Actin pre-mRNA. To purify yeast B act complexes for subsequent localization of proteins by negative-stain EM we used [ 32 P]-labeled pre-mRNA with three MS2 coat-protein-binding aptamers at the 5 ′ end (Zhou and Reed 2003) and incubated it under splicing conditions with yeast whole-cell extract from strains expressing a single spliceosomal protein tagged with the TAP tag (Rigaut et al. 1999 ). When we assembled B act complexes by the prp2-1 method (above), we heat-inactivated the Prp2 protein before incubation with the pre-mRNA. Following complex assembly we applied the MS2-MBP (maltose-binding protein) affinity-purification method (Zhou and Reed 2003; Fabrizio et al. 2009 ) and subjected the purified complexes to ultracentrifugation in a glycerol-density gradient in the presence of glutaraldehyde; this allowed the particles to be separated and (internally) cross-linked in a single step; the latter stabilizes them for examination by negative-stain EM .
As observed for other spliceosomal complexes, the B act complex is adsorbed to the carbon film of the EM sample grid in one preferential orientation, leading to one predominant viewing angle in electron micrographs ). This we term the "main view" of the B act complex. A schematic depiction of its 2D projection and representative class averages, together with raw images, are shown in Figure  1B and C. The main view of the B act complex has an overall "mushroom-like" shape with a "foot" protruding downward at the bottom center. This main view is asymmetric, with a steep slope shown on the left and a gradual or "shallow" slope on the right. The foot, steep slope, and shallow slope are positioned around a main body that extends into the foot. The overall length of the particle from the bottom of the foot to the upper end of the steep slope is ∼32 nm, and the width of the particle, between the outer edges of the steep and the shallow slope, is ∼29 nm.
To locate proteins in the yeast B act complex, we assembled spliceosomes in vitro in splicing-active yeast extracts from haploid strains expressing a single genetically tagged protein that was incorporated into the complex. We chose the tandem affinity-purification (TAP) tag (Rigaut et al. 1999 ) that we had already found to be suitable for immunolabeling and immunolocalization studies, both of the yeast tri-snRNP (Häcker et al. 2008 ) and of the B complex (Rigo et al. 2015) . As all the yeast strains used in this study were viable, we infer that addition of the TAP tag to these spliceosomal proteins did not affect splicing. The addition of polyclonal rabbit anti-TAP antibodies to affinity-purified B act complexes containing a single TAP-tagged protein led to spliceosome dimers that were purified and cross-linked by GraFix . Negative-stain EM and analysis of B act complex dimers were performed as previously described for the yeast B complex (Rigo et al. 2015) .
The U5 snRNP proteins are located in the foot, the main body, and the shallow slope of the B act complex After stable integration into the spliceosome, the tri-snRNP undergoes dramatic conformational and compositional changes. All the U1 and U4/U6 snRNP proteins, the U1 and U4 snRNA, and several U5 snRNP proteins leave the spliceosome, and only Brr2, Prp8, Snu114, the Sm ring, and the U5 and U6 snRNA molecules remain in it ). Our previous labeling study of the B complex (Rigo et al. 2015) as well as the recently published 3D structures of the yeast U4/U6·U5 tri-snRNP (Nguyen et al. 2016a; Wan et al. 2016) revealed that the U5 snRNP forms an elongated structure with Brr2 at one end, Prp8 and Snu114 in the middle, and the U5 Sm ring at the other end. Since Brr2 and Prp8 are relatively large proteins (246 and 280 kDa, respectively), we set out to locate the C and N termini of these proteins and also the C terminus of Snu114.
To locate the U5 snRNP protein Brr2, we fused a TAP tag to its C terminus, purified B act complexes as described above, added anti-TAP antibodies, and prepared EM specimens from the density-gradient fractions in which the spliceosomal dimers sedimented, corresponding to a sedimentation coefficient of 70S. The radioactivity measured in the fractions of the gradient (Supplemental Fig. S2 ) showed a peak in the range of 70S only when antibodies were added to TAP-tagged B act complexes (red curve). Without antibody addition (blue curve) there was no peak in the radioactivity signal in the 70S range. In addition, we analyzed the antibody content of the gradient fractions by an enzyme-linked immunosorbent assay (ELISA). The peak in the radioactivity signal at 70S colocalizes with a peak in the ELISA signal (green curve), which shows that the shift in sedimentation value of the spliceosomal particles is due to specific interaction with the anti-TAP antibodies. EM images of the particles from the 70S fractions of the gradient (Supplemental Fig. S3 ) clearly show that the particles were dimeric spliceosomes and that there was no unspecific particle aggregation. A corresponding observation was made for all TAP-tagged spliceosomal proteins that we investigated in this study (Supplemental Figs S2, S3) . In most cases only one particle of the dimer binds to the carbon film in the preferred orientation, thus showing the B act main view (Fig. 1C) ; we term this particle the "main-view" particle. For all proteins investigated, we took electron micrographs in sufficient number to obtain a data set of 50-100 "main-view" dimers and applied the localization method described previously (Rigo et al. 2015) .
This method makes use of the fact that the distance between the TAP tags of each spliceosome in a dimer cannot exceed 14 nm, as the length of each connecting Fab or Fc arm of the IgG molecule is 7 nm (Silverton et al. 1977) . Both domains of the TAP tag can be involved in anti-TAP antibody binding: the calmodulin-binding peptide (CBP) domain by binding to the antibody's Fab arm and the protein A domain by binding to the Fc arm (schematically depicted in Fig. 1D ). If two spliceosomal particles dimerize by the binding of both TAP tags to the Fc domain of a single IgG molecule, then the distance between the two TAP tags can be much shorter than 14 nm. As in most cases the IgG molecule is not discernible in the electron micrographs, we exploit the fact that the TAP tag of the main-view particle is constrained to be within 14 nm of the outline of the other particle; the latter serves as a marker (henceforth termed "marker particle").
Six B act complex dimers, representative of the whole data set of particles bearing a TAP tag at the C terminus of Brr2, are shown in Figure 1E . Three main classes of dimers regarding the relative orientation of the two particles were observed. In one class, the marker particle was connected to the mainview particle either at the bottom corner of the shallow slope ( Fig. 1E , frames 1-3), along the entire length of the shallow slope (Fig. 1E, frame 4) , or at the bottom edge of the shallow slope, involving the foot (Fig. 1E , frames 5 and 6). To identify the possible area in the main-view particle in which the antibody-binding site can be located, we traced the outline of the second particle (red line in the schematic drawings in the bottom row in Fig. 1E ) and extended it to 14 nm (transparent red area in Fig. 1E ).
The red area overlapping with the B act main-view particle encompasses all possible antibody-binding sites in the mainview particle of the respective dimer. For all main-view dimers in the data set, this area was determined individually. Next we aligned all these dimers according to the mainview particle, which led to overlapping of the individual areas of possible tag location. The intersection of all these individual areas, appearing as the darkest region at the bottom edge of the shallow slope, touching the main body, was then taken as the final-i.e., most precise-area where the TAP tag, and thus the C terminus of Brr2, is located (Fig. 1F) . In the same way we located the TAP tag of each protein investigated in this study.
We next located the N terminus of Brr2. In dimers with N-terminally tagged Brr2, the marker particle was connected to the main-view particle by the shallow slope as observed for C-terminally tagged Brr2. However, the marker particle was never found close to the foot. Instead, it was found at the top of the main view and also in contact with the steep slope ( Fig. 2A) . Because of this distribution of the marker particle, the area in which Brr2's N terminus is located, resulting from the overlap of all individual areas, was found in the top third of the shallow slope, extending into the top of the main body (sketch in Fig. 2A, lower right) .
The next protein we located was Prp8. As can be seen in Figure 2B , B act complex dimers harboring C-terminally tagged Prp8 reveal that the marker particle is attached to the shallow slope only. Applying the analysis method described above, we found the area where the C terminus of Prp8 is located to occupy the middle third of the shallow slope. When Prp8 was tagged N-terminally, a distribution of marker particles all around the main-view particle was observed, as exemplified by six representative dimers in Figure 2C , which led to the final area where Prp8's N terminus must be located, that is, in the center of the B act complex (i.e., the top part of the main body; sketch in Fig. 2C ).
We further located the C terminus of Snu114. As can be seen in Figure 2D , the dimerization occurred at different parts of the main-view particle, and points of attachment were located mainly in the bottom half of the B act complex, very often involving the foot. The final area where the C terminus of Snu114 was located in the B act complex main view thus lies in the bottom part of the main body, where it is connected to the foot (sketch in Fig. 2D ). Taken together, in the B act complex, the U5 snRNP proteins Prp8 and Snu114 occupy the main body, with Snu114 being located at the bottom of the main body.
The U2 snRNP proteins are located in the upper regions of the steep and the shallow slopes
In the B act complex several SF3a and SF3b complex proteins could be cross-linked to the pre-mRNA intron in a region upstream of the BPS . In addition, cross-links across the BP and at the 3 ′ end of the intron have been found for the SF3b protein Hsh155 (McPheeters and Muhlenkamp 2003; Schneider et al. 2015) . The location of U2 snRNP proteins, in particular Hsh155, could indirectly provide information about the location of the U2/pre-mRNA BP helix. To find the position of the U2 snRNP in the B act complex, we selected Lea1 (a protein that serves as a marker for the U2 snRNP's Sm ring; Caspary and Séraphin 1998), three SF3b complex proteins (Cus1, Hsh155, and Rse1), and two SF3a complex proteins (Prp9 and Prp11). For each of these proteins in turn, the TAP tag was introduced at the C terminus. For all of these U2 snRNP proteins, the resulting B act complex dimers showed similar distributions of the marker particle relative to the main-view particle. The connection interfaces between the marker particle and the main-view B act complex ranged from the upper part of the steep slope over the top center of the B act complex to various parts of the shallow slope (Figs. 3A-D, 4A,B) . No dimers were observed to be connected at the foot or at the bottom edges of the steep or the shallow slope. Applying our localization method described above, based on the 14 nm criterion, we found that the C termini of all the U2 snRNP proteins lie in the upper regions of the steep or the shallow slope. All areas touch the border of the main body of the B act complex. For the C terminus of Lea1 we found an area in the top corner of the steep slope at the border with the shallow slope FIGURE 2. Locations of U5 snRNP proteins in the yeast spliceosomal B act complex. EM images of B act complex dimers were taken at 115,000-fold magnification and dimers with at least one main-view particle were used for localization analysis. For each protein location, representative raw images of six dimers (left panels) and corresponding schematic drawing of the marker particle with the uniform main-view particle (right panels) are shown and numbered from 1 to 6. At the bottom, the location of the respective protein on the B act sketch was deduced by overlaying all dimers in the respective data set (left) and is depicted as a transparent dark area (right). ( Fig. 3A) , whereas the C terminus of Cus1 was located in the top third of the shallow slope, at the border with the steep slope (Fig. 3B) . The area where the C terminus of Hsh155 is located lies in the upper regions of the steep and the shallow slopes, where both slopes are connected (Fig. 3C) , overlapping in the shallow slope with the area where we found Cus1. The C terminus of Rse1 is located in the upper central part of the B act complex, exactly at the border of the steep and the shallow slope (Fig. 3D) .
The area in which we found the C terminus of Prp9 occupies the upper end of the steep slope and the border with the shallow slope (Fig. 4A) . We also located the C terminus of Prp11 in the top half of the steep slope, an area directly below that of Prp9 and closer to the center of the B act complex (Fig. 4B ). Taken together, the C termini of the SF3b complex proteins Rse1 and Cus1 reside in the top center of the B act complex extending into the upper region of the shallow slope, whereas the C terminus of Hsh155 is located in the upper regions of both the steep and the shallow slopes. The C termini of Lea1 and the SF3a complex proteins Prp9 and Prp11 occupy areas in the top center of the particle and reach into the upper region of the steep slope.
The RES complex colocalizes with the SF3b and SF3a proteins in the B act complex
The heterotrimeric RES complex is composed of Bud13, Snu17, and Pml1 (Dziembowski et al. 2004 ) and was found in immunoprecipitation experiments to interact with the SF3b complex (Wang et al. 2005) . Attempts to locate the C terminus of Snu17, which constitutes the core of the RES complex (Wysoczański et al. 2014), were not successful, since spliceosomal B act complexes harboring Snu17-TAP did not dimerize upon addition of anti-TAP antibodies (Supplemental Fig. S2 ). Therefore, we located the C terminus of Pml1. Six representative dimers are shown in Figure 4C : the distribution of the marker particle resembles that of the U2 snRNP proteins in that dimerization mainly occurs through regions located at the top of the steep and the shallow slopes. In addition, we observed dimers where the marker particle was connected on the side of the foot proximal to the steep slope. The resulting position of the C terminus of Pml1, therefore, lies in the middle of the steep slope extending into the upper part of the main body (sketch in Fig. 4C ) and colocalizes in part with the areas that we found for the U2 snRNP proteins.
Location of the 5
′ cap of the U2 and U5 snRNAs
The U2 and U5 snRNAs contain a 2,2,7-trimthylguanosine (m 3 G) cap structure, which is not present in the U6 snRNA and the pre-mRNA. To locate the 5 ′ ends of the U2 and U5 snRNA molecules, we dimerized the B act complexes by addition of a monoclonal anti-m 3 G antibody (H20) (Bochnig et al. 1987 ) and investigated the resulting dimers (Fig. 4D ), as described above for TAP-tagged proteins. We found a distribution of the marker particle all around the main view of the B act complex. When applying our localization method, based on the 14 nm criterion, to the data set obtained with the anti-cap antibody, we found two different areas of greatest overlap (sketch at the bottom of Fig. 4D ), (all other labeling experiments yielded only a single area). One cap area lay in the right-hand two-thirds of the foot and one in the upper part of the main body. Knowing that the U2 snRNP proteins are located at top center in the B act complex while the U5 snRNP proteins reach down to the foot, we assigned the area in the foot to the 5 ′ cap structure of the U5 snRNA and the area in the upper part of the main body to the cap structure of the U2 snRNA (Fig. 4D) .
NTC proteins are found in the central region and the steep slope of the B act complex
One major building block of the B act complex is the NTC (Supplemental Fig. S1 ). The NTC is thought to stabilize the FIGURE 4. Locations of two SF3a proteins, the RES complex protein Pml1, and the m 3 G cap of U2 and U5 snRNAs. Proteins were located as described in Figure 2 . For location of the m 3 G cap, two distinct areas within the B act complex schematic drawing were generated after overlaying all dimers formed by an anti-m 3 G cap antibody and were assigned to U2 and U5, respectively. rearranged RNA network of the spliceosome after the dissociation of the U4 snRNA and the U4/U6 proteins (Chan et al. 2003; Chan and Cheng 2005) . To gain insight into the organization of the NTC in the spliceosome at the B act stage, we located the C termini of five NTC proteins (Fig.  5) . When the TAP tag was fused to the C terminus of Prp19, we found spliceosome dimers in which the marker particle was connected to different regions of the steep slope, involving either the foot or the top end of the shallow slope (Fig. 5A) . The resulting area where the C terminus of Prp19 is located lies in the middle of the steep slope and reaches into the main body (sketch in Fig. 5A) .
A similar distribution of the marker particle was observed when B act complexes harboring C-terminally tagged Syf1 were dimerized. In this case, however, dimerization did not occur at the foot (Fig. 5B) . The final position of the C terminus of Syf1, therefore, lies in the upper part of the steep slope, at the border with the shallow slope (sketch in Fig. 5B ). In the case of C-terminally tagged Isy1, the distribution of marker particles resembled that of Syf1, with additional dimers created by a connection of the marker particle at the lower half of the shallow slope (Fig. 5C) . Thus, the final position of the C terminus of Isy1 lies in the upper region of the shallow slope at the border with the steep slope (sketch at the bottom of Fig. 5C ).
In the case of Cef1 the marker particles are distributed all around the main-view particle without any preferred side (Fig. 5D) . Consequently, the resulting area where the C terminus of Cef1 could be located traverses the upper main body and overlaps with the area that we found for Prp19 (sketch in Fig. 5D ).
In the case of Ntc20 we obtained a different distribution of the marker particle. All dimers showed a connection of the marker particle with the main-view particle at the bottom corner of the steep slope, in some cases involving the upper part of the steep slope or in other cases involving the foot (Fig. 5E ). Our analysis for the position of the C terminus of Ntc20 resulted in an area that occupies the bottom corner of the steep slope (sketch in Fig. 5E ).
Taken together, the NTC proteins are found in the upper central region of the B act complex and in a large part of the steep slope.
The C termini of the B act proteins Cwc2, Cwc21, and Cwc24 are located in the upper and central region of the B act complex
The last large group of proteins that takes part in building the B act complex is the set of the B act proteins (Supplemental Fig.  S1 ). We located the C termini of three proteins from this group: Cwc2, Cwc21, and Cwc24. Cwc2 was shown to be in contact with catalytically important RNA elements in the B act complex, including regions of U6 and the pre-mRNA intron near the 5 ′ SS and probably also the ISL of U6, thus placing Cwc2 at or near the spliceosome's catalytic center (McGrail et al. 2009; Rasche et al. 2012) . When the TAP tag was fused to the C terminus of Cwc2, the resulting dimers showed connection of the marker particle at the bottom, the middle, or the top end of the steep slope (Fig. 6A) . The resulting area where the C terminus of Cwc2 is located therefore lies in the middle of the steep slope, reaching into the top of the main body (sketch in Fig. 6A ). In the case of C-terminally tagged Cwc21 we observed a distribution of marker particles all around the main-view particle (Fig. 6B) , similar to the situation that we observed for the N terminus of Prp8 and the C terminus of Cef1. Thus the C terminus of Cwc21 is located in an area at the center of the main body (sketch in Fig. 6B ). Next we located Cwc24, which was shown to be required for step 1 but not for catalysis per se (Warkocki et al. 2009; Ohrt et al. 2012 ). C-terminally tagged Cwc24 treated with anti-TAP antibodies gave dimers in which the connection of the marker particle with the main-view dimer was seen at the top center of the B act complex, in the middle of the shallow slope, or at its bottom corner (Fig. 6C) . This distribution implied a final area for the location of Cwc24's Cterminal part as being in the top half of the shallow slope, where it is connected to the main body (sketch in Fig. 6C ), overlapping on the one side with the area where we found Hsh155 and on the other with the area where we found the C terminus of Prp8.
Prp2 and Spp2 are found in the upper central region of the B act complex
Catalytic activation of the spliceosome and the formation of the catalytically active B * complex requires the DEAH-box NTPase Prp2 and its cofactor Spp2 (Warkocki et al. 2009 (Warkocki et al. , 2015 . The action of the RNA helicase Prp2 depends on its interaction with Spp2 and the pre-mRNA intron at nucleotides downstream from the BPS (Liu and Cheng 2012) . To determine where these two proteins are situated in the B act complex, we assembled B act complexes on the truncated ActinΔ6 pre-mRNA construct and located on them the C terminus of Prp2 and the N terminus of Spp2. B act complexes stalled by using heat-inactivated extract derived from a yeast strain harboring the prp2-1 mutation do not contain Prp2 or Spp2 (Warkocki et al. 2009 ) and therefore could not be used. The ActinΔ6 construct allows efficient activation of the spliceosome (i.e., B act complex formation) but does not allow catalytic activation or the subsequent catalysis of step 1 of splicing (Cheng 1994; Fabrizio et al. 2009 ). Addition of the anti-TAP antibody to complexes harboring C-terminally tagged Prp2 led to dimers that showed a distribution of the marker particle similar to that observed for Cwc24, with a connection occurring either at the shallow slope or in the upper corner of the steep slope, in some cases involving the top edge of the steep slope (Fig. 6D) . The final area where the C terminus of Prp2 was located is shown schematically in Figure 6D and can be found in the top third of the shallow slope. An almost identical distribution of the marker particle was observed when the TAP tag was fused to the N terminus of Spp2 (Fig.  6E) . Thus, the resulting area where the N terminus of Spp2 is located overlaps with that of Prp2 in the top end of the shallow slope and reaches the border with the steep slope (sketch in Fig. 6E ).
DISCUSSION
We investigated the positions of twenty protein termini and two RNA molecules representing each building block of the spliceosomal B act complex by locating their C or N terminus or 5 ′ end, respectively, using a negative-stain EMbased immunolocation method developed previously (Rigo et al. 2015) . As summarized in Figure 7 , these protein locations provide insight into the structural organization of the yeast spliceosomal B act complex.
Brr2 performs a significant movement upon activation of the spliceosome Brr2, Prp8, Snu114, and the U5 snRNA (together with its Sm ring and the U6 snRNA molecule) are the only components of the tri-snRNP that remain bound to the spliceosome after activation ). In the B act complex we located the 5 ′ end of the U5 snRNA, the C terminus of Snu114, and the N and C termini of Brr2 and Prp8. We found that the N terminus of Brr2 and the C termini of Prp8 and Snu114 are lined up in the main body. Together with the position of the U5 RNA 5 ′ cap in the foot region, this arrangement resembles the U5 axis as previously identified by labeling of the yeast B complex (Rigo et al. 2015) . At the yeast tri-snRNP, a similar U5 axis was earlier inferred by EM labeling experiments (Häcker et al. 2008 ); more recently, its structure was determined at high resolution by cryo-EM 3D reconstruction (Nguyen et al. 2016a; Wan et al. 2016) . These findings establish the architecture of the U5 axis of the tri-snRNP with the U5 Sm ring at the lower foot and the U5 5 ′ cap close by and just above these, Snu114 including its C terminus, followed by the large Prp8 N-terminal and central RT/En domains. This architecture appears to be present in the B act complex as well, since it is highly consistent with our labeling results. Indeed, a similar architecture was also found in a later stage of the spliceosome cycle by cryo-EM reconstruction of the S. pombe ILS (Yan et al. 2015) . This axis appears to be a central docking domain of the spliceosome. However, the position of Brr2 in the B act complex differs significantly when compared with that in the yeast trisnRNP as well as that of the B complex. In the cryo-EM structure of the yeast tri-snRNP, the Brr2 tandem helicase cassettes continue the U5 axis with the C-terminal cassette at the top end. A Brr2 arrangement such as that in the yeast tri-snRNP is also present in the B complex, since the C terminus of Brr2 was located by EM-labeling at the top end of its U5 axis, a location very similar to that of the labeling position in the yeast tri-snRNP (Häcker et al. 2008; Rigo et al. 2015) . The long U5 axis of the yeast tri-snRNP and the corresponding axis in the B complex are also very similar in their appearance (Häcker et al. 2008; Rigo et al. 2015) . In the yeast B act complex we have now found the Brr2 helicase cassettes in a different orientation relative to the canonical U5 axis: Brr2's C terminus, which is placed directly at the outer end of the C-terminal cassette, is found at the bottom of the shallow slope and points downward rather than upward. As the position of Prp8's C terminus in the upper shallow slope region marks the position of Brr2's N-terminal cassette (Prp8's C-terminal Jab1 domain binds tightly to Brr2's N-terminal cassette [Mozaffari-Jovin et al. 2013; Nguyen et al. 2013] ), the tandem helicase is obviously positioned in the shallow slope with the C-terminal cassette tilted downward. This observation defines a substantial structural change during the transition from the B to the B act complex and may be a consequence of Brr2's helicase activity that unwinds the U4/U6 duplex.
The U2 snRNP and the RNA helicase Prp2 are located in the upper regions of the B act complex
The positions of the U2 proteins investigated in this work are summarized in Figure 7B and C, which show that they all are located in the upper central region of the B act complex, indicating that the U2 snRNP remains a compact entity in the B act complex. By comparing the U5 snRNP protein positions (Fig. 7A) with the positions of the U2 snRNP proteins (Fig.  7B,C) , it can be seen that the N terminus of Brr2 and its N-terminal helicase cassette (area where the C terminus of Prp8 is located) overlap with Cus1 in the upper region of the main body and at the top of the shallow slope, respectively. Although overlapping areas in 2D projections might not necessarily reflect a colocalization in 3D space, here proximity does seem possible, and indeed binding between human U5 and U2 snRNP proteins has been found by a yeast twohybrid screen and a coimmunoprecipitation study (Hegele et al. 2012) . Among other proteins, Cus1 and Brr2 have been found to interact with each other. The position of Lea1 indicates the region where the U2 Sm ring is located, as it binds together with Msl1, to a U2 snRNA stem-loop downstream from the Sm binding site (Price et al. 1998) . During catalytic activation of the spliceosome (from B act to B * ), the BP adenosine has to be exposed and freed from SF3a and SF3b proteins before the first catalytic step of splicing can take place, which is achieved by the action of the DEAH-box helicase Prp2 together with its cofactor Spp2 (Warkocki et al. 2009; Lardelli et al. 2010; Liu and Cheng 2012) . Prp2 requires Spp2 for activating the spliceosome, which is consistent with our finding that the areas where we found these two proteins overlap in the B act complex (summarized in Fig. 7D ). Prp2 binds to the pre-mRNA downstream from the BP (Liu and Cheng 2012) in a region where Hsh155 and the RES complex could be cross-linked to the intron . These observations make it seem very likely that the overlapping areas-or close proximities-of Prp2, Spp2, Pml1, and Hsh155 reflect real physical proximity of these proteins. The respective termini are probably positioned on the same side (front or back) of the particle.
NTC proteins reside in or close to the steep slope
Besides the U2 and U5 snRNPs, one major building block of the B act complex is the NTC, which stabilizes the newly formed, catalytically active RNA network made up of the U2, U6, and U5 snRNAs (Hogg et al. 2010) . To locate the NTC and gain insight into the global architecture of the B act complex, we located five of the 10 NTC core proteins: Prp19, Syf1, Cef1, Isy1, and Ntc20.
In the recent cryo-EM 3D reconstruction of the S. pombe ILS (Yan et al. 2015) , several NTC proteins are modeled within the complex; therefore we compared the location of NTC proteins in our B act with this ILS complex. For Syf1 (Cwf3 in S. pombe) in the ILS, the N-terminal part of its TPR repeats starts above Cwc2 (Cwf2) and the C-terminal part approaches the RT domain side of Prp8 (Spp42). Our localization of the C terminus of Syf1 in the B act complex fits in well with a TPR arrangement, as seen in the ILS. As we found Cwc2 at the interface between the U5 axis and the steep slope, which would mark the N-repeats, the TPRs could pass through the B act complex within the steep slope and end at the Syf1 C terminus position in the upper part of the steep slope. At the lower tip region of the steep slope we located the C terminus of the small protein Ntc20, which is present only in S. cerevisiae spliceosomes. Its location fits in well with the assignment of the steep slope as being the domain of the B act complex that contains the NTC proteins. When orienting the ILS structure with the U5 axis pointing straight up (with U5 Sm at the bottom) and with Syf1 and Clf1 (Cwf4) protruding sideward (Fig. 7F) , the Cwc2 protein becomes positioned between the U5 axis and the Syf1/Clf1 proteins, reflecting exactly the topology of the positions at which the B act complex was labeled.
Two other important NTC proteins that we have located are Prp19 and Cef1 (Cdc5). The Prp19 protein consists of an N-terminal ubiquitin ligase U-box domain, a 10-nmlong α helix, and a WD40 domain at its C terminus; four copies of it are present in the NTC complex and the spliceosomes. The helices from two copies form a long parallelarranged coiled coil (Fig. 7F) . The two pairs are joined at their N termini, so that a 20-nm-long rod-like structure with the C termini at its ends is created (Yan et al. 2015) . In the ILS structure this rod-like structure runs diagonally from the central, upper region where Syf1's and Clf1's TPRs are located to the lower foot region containing the U5 Sm ring. The C terminus of Cef1 (Cdc5) is located at its lowest position. In the B act complex we found Cef1's C terminus and the C termini of Prp19 further up at the main body, in part reaching into the steep slope, indicating a different arrangement of the Prp19/Cef1 rod-like structure at the B act spliceosomal stage.
Direct and indirect localization of RNA elements reveal the position of the catalytic center in the B act complex
We found the 5 ′ ends of the U2 and U5 snRNAs directly by locating their m 3 G cap structures. Furthermore, we were able to deduce indirectly the positions of certain RNA elements that have been shown to interact with the proteins that we located in the B act complex. The positions of important RNA elements, as deduced from our localization experiments, are shown in Figure 7G . Lea1 is the yeast homolog of the human U2-A ′ , which has been shown to form a complex with U2-B ′′ (the human ortholog of Msl1) and with loop IV at the 3 ′ end of the U2 snRNA (Price et al. 1998) . Thus, from the position of Lea1 we can indirectly determine the positions of loop IV and the Sm ring of the U2 snRNA. Lea1, and therefore the 3 ′ end and the Sm ring of the U2 snRNA, lie in the upper region of the steep slope, where it connects to the shallow slope (Fig. 7G) .
From the position of Cwc2, which could previously be cross-linked to the U6 ISL and to the pre-mRNA close to the 5 ′ SS (McGrail et al. 2009; Rasche et al. 2012 ) and was located here in the middle of the steep slope, reaching into the upper half of the main body, we can conclude that the U6 ISL and the 5 ′ SS are located in the middle and upper region of the main body (Fig. 7G) .
In addition to these indirect localizations of RNA molecules, we also directly located the 5 ′ end of the U2 snRNA, which is positioned in the center of the main body of the B act complex (Fig. 7B) . The 5 ′ end of the U2 snRNA base pairs with the 3 ′ end of the U6 snRNA to form helix II and the U2 snRNA sequence 3 ′ of helix II is involved in forming the helices Ia and Ib with the U6 snRNA which are part of the catalytically active RNA network (Madhani and Guthrie 1994; Hilliker and Staley 2004; Mefford and Staley 2009) .
We further located the 5 ′ end of the U5 snRNA in the right half of the foot (Fig. 7A) . The U5 axis extends from the bottom tip of the foot to the center of the main body and is made up of the Sm core, Snu114, and Prp8. As discussed above, it is feasible to conclude that the 3D organization of the U5 axis is preserved in the B act complex as well. On the basis of this assumption, we were able to place the active-site cavity of Prp8 Nguyen et al. 2015) and the U5 snRNA loop I that is close to the 5 ′ SS (McConnell and Steitz 2001) in the center of the main body of the B act complex. Taken together, direct and indirect RNA localizations place the U2/U6 helices Ia, Ib, and II in the center of the main body where the U6 ISL-and most probably also the 5 ′ SS-reside (Fig. 7G) . From all these inferred RNA positions we can conclude that the catalytically important U2/U6/U5/ pre-mRNA network, and thus the catalytic center of the spliceosome, lie in the center of the main body of the B act complex (Fig. 7G) .
From the locations of the SF3b complex proteins Hsh155, Cus1, and Rse1, we determined that the SF3b complex lies in the upper one-third of the B act complex, ranging from the upper region of the shallow slope to the top part of the steep slope. The area where we located the SF3a proteins Prp9 and Prp11 overlaps with the position of the SF3b complex but does not extend to the shallow slope (Fig. 7B) . The SF3a complex is positioned in the upper half of the steep slope of the B act complex. Various nucleotides of the pre-mRNA intron around the BPS region, as well as downstream from the BP up to the 3 ′ SS, have been cross-linked to Hsh155 . In the same study, pre-mRNA nucleotides upstream of the BPS were found to cross-link to Cus1, Prp9, and Prp11 in the B act complex and nucleotides at the 3 ′ end of the intron have been found to cross-link to RES complex proteins (discussed above). From these protein locations we can conclude that the U2/pre-mRNA BP helix must be located close to, perhaps a bit upward, of the center of the main body, where we placed the emerging catalytic center of the B act complex.
MATERIALS AND METHODS

Strains and plasmids
Yeast strains expressing the respective C-or N-terminally TAPtagged proteins had either been constructed previously (Häcker et al. 2008; Rigo et al. 2015) or were produced in this work according to the method described earlier (Puig et al 2001) ; they are listed in Supplemental Table S1 . Four parental strains are used in this work, including TR2 (Mat a, trp1-Δ1, his3-Δ, ura3-52, lys2-801, ade2-101); YPH499 (Mat a, ura3-52, lys2-801, ade2-101, trp1-Δ63, his3-Δ200, leu2-Δ1); prp2-1 (Mat α, prp2-1, ade2, his3, lys2-801, ura3, carrying a G360D substitution in the helicase domain of Prp2); and BJ2168 (Mat a, gal2, leu2, pep4-3, prc1-407, prb1-1122, trp1, ura3-52) . The yeast strains expressing the respective C-terminally TAP-tagged proteins obtained from Euroscarf were tagged in the parental strain (Mat a, ade2, arg4, . Plasmid pBS1479 (Puig et al. 2001 ) was used as a template to amplify the C-terminal TAP cassette and then fused to the C terminus of the respective protein by PCR. Plasmid pBS1761 (Puig et al. 2001 ) was used for constructing the N-terminally TAP-tagged proteins mainly as described in Puig et al. (2001) . In some cases the TEV protease cleavage site of the TAP tag was replaced by a PreScission protease cleavage site. In those cases the plasmid pBS1539-Psc (Kramer et al. 2014 ) was used as PCR template. No differences were found in the growth of the TAP-tagged strains as compared to their untagged parental strains, as previously described (Rigo et al. 2015) .
Purification and immunolabeling of spliceosomal B act complexes
Spliceosomal B act complexes were assembled and purified according to the methods described previously Warkocki et al. 2009; Rigo et al. 2015) . Uniformly [ 32 P]-labeled M3-Actin wild-type or M3-ActinΔ6 pre-mRNAs, retaining 6 nt downstream from the BS, were produced by transcription in vitro with T7 RNA polymerase and preincubated with a 15-fold molar excess of the MS2-MBP fusion protein in 20 mM HEPES (pH 7.9) at 4°C for 30 min. The MS2-MBP-bound pre-mRNA was then incubated for 60 min with yeast whole-cell extract under splicing conditions (60 mM K 2 HPO 4 /KH 2 PO 4 pH 7.4; 3% w/v PEG-8000; 2 mM ATP; 2 mM spermidine; 2.5 mM MgCl 2 ; 40% v/v yeast extract; 2 nM pre-mRNA at 30-50 cpm/fmol). After complex assembly, the potassium concentration was adjusted to 150 mM and the precipitate was removed by centrifugation for 10 min at 13,300g and 4°C. The supernatant was loaded onto amylose-agarose (New England Biolabs) pre-equilibrated in G150 buffer (20 mM HEPES-KOH pH 7.9; 1.5 mM MgCl 2 ; 150 mM KCl; 0.5 mM DTT; 0.5 mM PMSF) containing 5% w/v glycerol and 0.01% w/v NP-40. After washing with 10 mL of G150 buffer and 50 mL of G75 buffer (20 mM HEPES-KOH pH 7.9; 1.5 mM MgCl 2 ; 75 mM KCl; 0.5 mM DTT; 0.5 mM PMSF) containing 5% w/v glycerol and 0.01% w/v NP-40, B act complexes were eluted with 12 mM maltose in G75 buffer containing 5% w/v glycerol and 0.01% w/v NP-40. From the peak fractions, 4-14 pmol of B act complexes were taken and incubated for 90 min on ice with rabbit polyclonal anti-TAP antibodies (Thermo Fischer Scientific) in a molar ratio from 1:1 to 1:4. For cap localization, instead of anti-TAP antibody, mouse monoclonal anti-cap antibody (H20; Bochnig et al. 1987 ) was used. The control was incubated for 90 min on ice but without antibodies. After antibody binding, the whole volume was loaded onto a 10%-30% w/v glycerol gradient with 0%-0.04% or 0%-0.1% w/v glutaraldehyde (Electron Microscopy Sciences) gradient in G75 buffer and centrifuged at 4°C in a Sorvall TH660 rotor for 16 h at 51,000g (max.). The gradients were harvested from the bottom in 125 µL fractions. The peak fractions were used directly for EM specimen preparation. To confirm the presence of the antibody in the gradient fractions, ELISA was carried out essentially as described by Wolf et al. (2009) . To obtain a better ELISA signal, we also used the PAP complex (peroxidase-anti-peroxidase complex) (Sigma-Aldrich) in addition to anti-TAP antibodies in the cases of Hsh155, Rse1, and Spp2. The gradient profiles and ELISA results were drawn with the software Graphpad Prism (Graphpad Software Inc.). grid preparation, ∼25 µL of the peak gradient fraction was first quenched with 50 mM glycine and then pipetted into a well in a polyoxymethylene block precooled on ice. The sample was then covered with a thin (<10 nm) carbon film and a perforated carbon copper mesh grid. Particles in the sample were allowed to adsorb onto the carbon film for typically 120-180 min. The adsorbed particles were then transferred to another well on the polyoxymethylene block containing 2.5% w/v uranyl formate (in ddH 2 O) and stained for 2.5 min on ice. After staining, grids were dried at room temperature for ∼10 min and stored until image acquisition. EM images were taken in a CM200 FEG microscope (FEI) with 160 kV acceleration voltage in eucentric height and a defocus of ∼1.2 µm using a 4k × 4k CCD camera (TVIPS) with twofold binning of the pixels. Images were taken at a magnification of 80,000 for class averages and 115,000 for protein localization analysis. For class averages, ∼12,800 single-particle images of Cwc2 TAP-tagged monomeric yeast B act complexes were collected and image processing was performed according to Rigo et al. (2015) . For locating proteins, complex dimers of each tagged protein in which the morphology of the main-view particle were clearly recognized, were collected from raw images and used for mapping the location of the tagged protein in the B act complex on the basis of the procedure described in the main text.
For Brr2-TAP, Prp8-TAP, Snu114-TAP, and Prp2-TAP, to rule out bias, the collection of the dimer images was carried out independently by two different persons, yielding two partly overlapping data sets for each protein. Analysis of each data set was performed independently by three different persons and yielded a largely identical localization result for each respective protein. For Cwc2-TAP, two independent labeling experiments applying the same method were performed, resulting in two independent data sets. Independent analysis of these two data sets by three persons yielded the same localization result. The agreement between the results of these parallel, independent analyses supports the claim that our method is adequately objective.
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